Dangerous Diabetes Drugs: Byetta

Incretin Mimetic Drug Lawsuits Consolidated in Federal Court

On August 28, 2013, it was announced that litigation involving incretin mimetic drugs Byetta, Victoza, Januvia, and Janumet are being consolidated into multi-district litigation in California federal court.  Usually lawsuits against different companies, as is in this case, are not consolidated into one MDL.  In this case however, many of the plaintiffs bringing the lawsuits…

Posted in Byetta, Dangerous Diabetes Drugs, Januvia, Victoza | Leave a comment

Medical Journal Links Byetta, Januvia to Pancreatitis, Pancreatic Cancer, and Thyroid Cancer

After reviewing the data from the adverse events reported to the FDA, researchers found that there was a six-fold increase in association between pancreatitis and Byetta and Januvia.  These results were published in the medical journal Gastroenterology. The scientists found other associations as well, including a threefold increase in pancreatic cancer, and a four-fold increase…

Posted in Byetta, Dangerous Diabetes Drugs, Januvia | Leave a comment

Timeline of FDA Action: Byetta

Byetta is a GLP-1 agonist injection manufactured by Amylin Pharmaceuticals, Inc.  It was approved by the FDA in 2005.  Its generic name is exenatide. Byetta is administered twice daily by injection, but also comes in a once-weekly form called Bydureon. Byetta works by forcing the pancreas to increase insulin production and to suppress release of…

Posted in Byetta, Dangerous Diabetes Drugs | Leave a comment